🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An open label, single-arm clinical study evaluating the safety and efficacy...
Status
Unknown
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2022-04-28
Trial ID
NCT05266768
Treatments Being Tested
RAPA-501-ALS is a phase 2/3 expansion cohort study of RAPA-501 autologous h...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2025-01-02
Trial ID
NCT04220190
Treatments Being Tested
This phase I trial studies the side effects and best dose of genetically mo...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2013-10-08
Trial ID
NCT01815749
RATIONALE: Gene-modified lymphocytes may stimulate the immune system in dif...
Status
Terminated
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2008-06
Trial ID
NCT00704938
This study investigates the infusion safety and potential curative properti...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2021-09-12
Trial ID
NCT04764513
Treatments Being Tested
The purpose of this study is to determine the safety and efficacy of post-t...
Status
Completed
Location
UAB Medical Center (University of Alabama at Birmingham)
Start Date
2014-10-09
Trial ID
NCT02193880
Treatments Being Tested
The purpose of this study is to test whether abatacept, a drug approved by ...
Status
Terminated
Location
Vanderbilt University Medical Center
Start Date
2014-08
Trial ID
NCT02232880
RATIONALE: Giving high-dose chemotherapy drugs, such as carmustine, etoposi...
Status
Completed
Location
City of Hope Medical Center
Start Date
2000-05-10
Trial ID
NCT00641381
To determine the maximum tolerated dose and/or optimum biologic dose of MED...
Status
Completed
Location
Research Site
Start Date
2010-12
Trial ID
NCT01284231
The purpose of this early (phase I/II) clinical trial is to assess the effe...
Status
Terminated
Location
Yale School of Medicine
Start Date
2011-06-01
Trial ID
NCT01350401
Treatments Being Tested